510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K101651Substantially Equivalent

Angioguard Xp Emboli Capture Guidewire, Angioguard Rx Emboli Capture Guidewire

Cordis US Corp., Bridgewater NJ / Special, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K101651 is the FDA 510(k) clearance record for ANGIOGUARD XP EMBOLI CAPTURE GUIDEWIRE, ANGIOGUARD RX EMBOLI CAPTURE GUIDEWIRE, a class II device, cleared for Cordis Corp. on under FDA product code NTE (Temporary Carotid Catheter For Embolic Capture). FDA's definition for product code NTE reads: "This device is a single use percutaneous catheter system that is introduced into an artery through the skin using a guidewire. The catheter has an embolic capture filter or an occlusion balloon at the distal end. The filter or balloon can...". FDA records list 332 510(k) clearances for Cordis US Corp., from to . As of , FDA records show no recalls naming K101651.

Clearance record

Decision date
Received
(28 days to decision)
Product code
NTE Temporary Carotid Catheter For Embolic Capture
Regulation
21 CFR 870.1250
Device class
Class II
Review panel
Cardiovascular
Applicant
Cordis Corp. 430 Rte. 22 E., Bridgewater NJ
510(k) summary
Summary PDF
Third party review
No

Clearances, product code NTE

Trailing 12 months

FDA records hold no clearances under product code NTE in the trailing twelve months.

FDA records show no clearances under product code NTE in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code NTE, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260